IHS Chemical Week

Regions :: Western Europe :: U.K.

AbbVie to acquire Shire for $55 billion

1:12 PM MDT | July 18, 2014 | Natasha Alperowicz

The boards of AbbVie (North Chicago, IL) and Shire (Dublin) announced today that they have reached agreement for AbbVie to acquire Shire for approximately £32 billion ($54.7 billion). The price represents a premium of approximately 53% to the price of Shire shares on 2 May, the last business day prior to AbbVie’s initial proposal. The companies say that the transaction will create a well-positioned specialty biopharmaceutical company with sustainable leadership positions within areas of unmet need, including immunology, rare diseases, neuroscience...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa